Skip to content
DataLookout
Menu

NCT07894458

MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Two-year recurrence-free survival rate
Timeframe: Time from curative surgery to confirmation of clinical progression (recurrence or metastasis) within two years.

Secondary (2)

Overall survival
Timely diagnosis rate by the novel MRD monitoring technique

Arms and interventions

MRD-Guided Adaptive Postoperative Management GroupExperimental

Other: Adaptive therapy of de-escalation and escalation based on MRD testing and pathological response

Sites

1 site in 1 country

  • Peking University People's HospitalBeijing, Beijing Municipality, China